不同外周动脉疾病分期的十年死亡率:一项基于人群的观察性结局研究
2004-2005年随机纳入5080名受试者,通过问卷和踝肱指数(ABI)划分外周动脉疾病(PAD)严重程度,随访至2015年底利用瑞典国家死因登记分析十年死亡率。结果显示全因死亡率随PAD分期加重而升高,无症状PAD、间歇性跛行和严重肢体缺血患者心血管死亡风险均显著高于参照人群。
要点
- 十年全因死亡率:参照人群27%,无症状PAD 56%,间歇性跛行63%,严重肢体缺血75%。
- 全部PAD患者中,心血管原因作为主要死因占45%,心血管事件作为主要或前三位贡献死因占64%。
- 年龄调整后心血管主要死因的风险比:无症状PAD 1.9,间歇性跛行2.6,严重肢体缺血3.5。
核心结论
- PAD患者包括无症状PAD患者仍有高心血管死亡风险,有症状PAD患者死亡风险较参照人群增加一倍以上,且随PAD分期加重而升高,仍需提高对PAD的认识并改进风险降低管理。
研究设计与样本
- 基于人群的观察性研究,2004-2005年随机选取5080名受试者,完成健康状态问卷和踝肱指数测量以进行PAD严重程度分期并设立参照组,随访至2015年底,通过瑞典政府国家登记数据库获取死因数据并与2005年基线PAD分期比较。
主要发现
- 十年全因死亡率:参照人群27%,无症状PAD 56%,间歇性跛行63%,严重肢体缺血75%。
- 全部PAD患者中,心血管原因作为主要死因占45%,心血管事件作为主要或前三位常见贡献死因之一占64%。
- 年龄调整后心血管事件作为主要死因的风险比:无症状PAD 1.9(95%CI 1.5-2.3),间歇性跛行2.6(95%CI 2.1-3.4),严重肢体缺血3.5(95%CI 2.3-5.2)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim was to determine long-term mortality rates and the underlying cause of death for subjects with different peripheral arterial disease (PAD) stages in a population based setting. METHODS: A randomly selected population sample of 5080 subjects was enrolled in the study in 2004-2005. Participants completed health state questionnaires and underwent ankle brachial index (ABI) measurements for classification into PAD severity stages and reference subjects. A follow-up was conducted by the end of 2015 using data from Swedish governmental national registers for cause of death, which was then compared with PAD stage determined at baseline in 2005. RESULTS: The 10 year all cause mortality was 27% for reference cases, 56% for asymptomatic PAD (APAD), 63% for intermittent claudication (IC), and 75% for severe limb ischaemia (SLI). Among all PAD subjects, cardiovascular (CV) causes were the most common main cause of death (45%) and a CV event was present as either the main or one of the three most common contributing causes of death in 64% of the cases. The age adjusted hazard ratios for a main cause of death by a CV event were 1.9 (95% CI 1.5-2.3) for APAD, 2.6 (95% CI 2.1-3.4) for IC, and 3.5 (95% CI 2.3-5.2) for SLI. CONCLUSION: PAD subjects, including the APAD subjects, are still at high risk of CV death. The mortality risks are more than doubled in symptomatic PAD patients compared with reference subjects and increase by severity of PAD stage. Awareness and improved risk reduction management of PAD are still warranted.
引用
- Sartipy F, Sigvant B, Lundin F, et al. Ten Year Mortality in Different Peripheral Arterial Disease Stages: A Population Based Observational Study on Outcome. Eur J Vasc Endovasc Surg. 2018. PMID: 29478910. doi:10.1016/j.ejvs.2018.01.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。